JACOBUS 25 102 (Dapsone 25 mg)
Pill imprint JACOBUS 25 102 has been identified as Dapsone 25 mg.
Dapsone is used in the treatment of leprosy, tuberculoid; leprosy; pneumocystis pneumonia; toxoplasmosis, prophylaxis; pneumocystis pneumonia prophylaxis (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for JACOBUS 25 102 (Dapsone 25 mg)
- 25 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Jacobus Pharmaceutical Company
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|54868-2817||Physicians Total Care Inc (repackager)|
|55289-0188||PDRX Pharmaceuticals Inc (repackager)|
|68258-9091||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Dapsone is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...